Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 6,000 shares at $42.88 ($257K) on 2021-12-15, disclosed to the SEC on 2021-12-17.
Open-market sale of $257k APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.88 | 3,000 | $129K | 50.0% |
| 2 | $42.88 | 3,000 | $129K | 50.0% |
| Total | $42.88 avg | 6,000 | $257K | 100% |
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-09-18 | $113K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |